Pharmaceuticals and Healthcare Reports Australia Healthcare Market | Page 2

In 2015, the government spent $22.03 billion on R&D on medical and health science and exported
$3.53 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $22.30
billion in 2015 and is projected to reach $25.20 billion by 2020, at a Compound Annual Growth Rate
(CAGR) of 2%. The medical device market was valued at $8.85 billion in 2015 and is projected to
grow at a CAGR of 0.1% to $11.44 billion by 2020. These positive growth trends can be primarily
attributed to -
- An increasingly elderly population
- Universal health coverage
- Government initiatives
Request a Sample Copy of This Report @
http://www.radiantinsights.com/research/countryfocus-healthcare-regulatory-and-
reimbursement-landscape-australia/request-sample
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in
Australia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size,
segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Alphapharm,
Apotex, Aspen Pharmacare (Aspen), Pfizer and AstraZeneca; and profiles and SWOT analyses of the
major players in the medical device market: GE Healthcare, Siemens Healthcare, Philips Healthcare,
GSK and Alcon
- An insightful review of the reimbursement and regulatory landscape, with analysis covering details
of the country's healthcare reimbursement process, regulatory agencies and the approval processes
for new drugs and medical devices
- Detailed analysis of the country's political and economic environment, covering economic
indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Australian healthcare market
Reasons To Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Australia's
healthcare market
Follow Us: